|
| Brief about the Show: |
|
| OMICS Group invites all the participants across the globe to attend the 4th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R & D Summit during May 20-22, 2013 at DoubleTree by Hilton Beijing, China. BABE-2013 is a scientific platform to meet fellow key decision makers all-around the Academic Institutions, Healthcare Institutes, Pharmaceutical, Biotech, CROs supply chain, Logistics practitioners making the congress a perfect platform to share experience, foster collaborations through the research talks & presentations to put forward many thought provoking strategies in Bioequivalence and Bioavailability, making the congress a perfect platform to share proficiency. |
|
Who Should Visit?
|
Healthcare Institutes |
|
Pharmaceutical |
|
Biotech |
|
CROs supply chain |
|
Logistics practitioners |
|
Important Topics
|
Current Issues on Bioavailability and Bioequivalence (BA/BE) Determination |
|
Drug Design, Discovery, and Development |
|
PK/PD Models, Biowaivers, and Biosimilars |
|
Oral Bioavailability Enhancement |
|
Pharmacokinetics and BA/BE |
|
BA/BE of Novel Drug Delivery Systems |
|
Strategies and Challenges in Bioanalysis |
|
Bioavailability of Pharmaceuticals, Nutrients, and Other Supplements |
|
Regulatory and Economic Aspects of BA/BE |
|
Bioavailability, Bioequivalence, and Drug Product Selection |
|
|
Benefits Of Visiting
|
Make new contacts |
|
B2B-partnering |
|
Promotional Opportunities |
|
Sharing of practical regulatory and industry experience |
|
One-on-one networking opportunities with regulatory representatives and industry peers |
|
Other Highlights
|
Current FDA Priorities and Perspectives |
|
Biochemical mechanisms of drug toxicity |
|
Skill Set for Biosimilars Development |
|
Challenges and Opportunities for Regulatory Approval in China |
|
|
|
| Organizer: |
|
|
|
|
|
|
|
|
|
|
Welcome to
IndianPharma.in
|
|